foxo4-dri senolytic peptide 2023 2024 Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis Senolytic therapeutics: An emerging treatment
Senolytic therapeutics: An emerging treatment modality for osteoarthritis ScienceDirect Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI 10mg Ion Peptide
Pay in 4 interest-free payments of $6.81 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



